Imatinib Mesylate Tablet, Film Coated
Product Images NDC 68001-491

8 FDA label images from Bluepoint Laboratories · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Imatinib Mesylate (NDC 68001-491). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Imatinib-structure (Imatinib Structure)

Imatinib-structure (Imatinib Structure)
Chemical structure of imatinib mesylate, showing its molecular arrangement including aromatic rings, nitrogen atoms, and the methanesulfonic acid (mesylate) group.*
FDA Label Image

Spl-imatinib-fig1 (Spl Imatinib Fig1)

Spl-imatinib-fig1 (Spl Imatinib Fig1)
A Kaplan-Meier survival curve chart depicting percent of patients without progression over time in months since randomization for two treatment arms: Imatinib Mesylate and IFN+Ara-C. The chart includes number of patients at progression and censoring, hazard ratio with confidence interval, and statistical significance (P<0.0001). Imatinib Mesylate shows higher progression-free survival compared to IFN+Ara-C throughout the 72-month period.*
FDA Label Image

Spl-imatinib-fig2 (Spl Imatinib Fig2)

Spl-imatinib-fig2 (Spl Imatinib Fig2)
A Kaplan-Meier survival curve comparing the percentage without progression to AP or BC over 72 months since randomization for two treatment arms: imatinib mesylate and IFN+Ara-C. The chart includes patient numbers at various follow-up points and hazard ratio with confidence interval, indicating a statistically significant difference favoring imatinib mesylate.*
FDA Label Image

Spl-imatinib-fig-3 (Spl Imatinib Fig 3)

Spl-imatinib-fig-3 (Spl Imatinib Fig 3)
A Kaplan-Meier survival curve comparing the probability of being alive and recurrence-free over time (in months) between Imatinib 400 mg and placebo groups. The graph shows the number of patients at risk at various time points and indicates censored data points, illustrating survival differences between the two treatments.*
FDA Label Image

Spl-imatinib-fig-4 (Spl Imatinib Fig 4)

Spl-imatinib-fig-4 (Spl Imatinib Fig 4)
A Kaplan-Meier survival curve chart illustrating the probability of recurrence-free survival over time in months for imatinib mesylate treatment at 12 months versus 36 months. The graph shows survival probabilities on the vertical axis and survival time in months on the horizontal axis, comparing two groups with censored observations marked. Event and at-risk numbers are included below the main graph.*
FDA Label Image

Spl-imatinib-fig-5 (Spl Imatinib Fig 5)

Spl-imatinib-fig-5 (Spl Imatinib Fig 5)
A survival curve chart comparing probability of overall survival over time in months for two groups receiving imatinib mesylate: one for 12 months and another for 36 months. The chart includes hazard ratio, p-value, number at risk, events, and censored observations, illustrating survival differences between the two treatment durations.*
FDA Label Image

100mg Label (Image 01)

100mg Label (Image 01)
Label for Imatinib Mesylate Tablets 100 mg from BluePoint Laboratories. The label states the medicine is Rx only, contains 90 tablets, and includes storage instructions. Manufactured by Sun Pharmaceutical Industries Ltd. in India. The label includes a barcode, dosage strength, and a usage notice.*
FDA Label Image

400mg Label (Image 02)

400mg Label (Image 02)
Imatinib Mesylate 400 mg film-coated tablets label from BluePoint Laboratories. The label indicates the package contains 30 tablets for oral use. Manufactured by Sun Pharmaceutical Industries Ltd., India. Includes storage instructions, dosage note, barcode, and placeholder for GTIN, lot, expiration, and serial numbers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.